UA96427C2 - Substituted pyrazole compounds - Google Patents
Substituted pyrazole compoundsInfo
- Publication number
- UA96427C2 UA96427C2 UAA200805165A UAA200805165A UA96427C2 UA 96427 C2 UA96427 C2 UA 96427C2 UA A200805165 A UAA200805165 A UA A200805165A UA A200805165 A UAA200805165 A UA A200805165A UA 96427 C2 UA96427 C2 UA 96427C2
- Authority
- UA
- Ukraine
- Prior art keywords
- pyrazole compounds
- substituted pyrazole
- aurora
- disclosed
- inhibitors
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Disclosed are protein kinase inhibitors, compositions comprising such inhibitors, and methods of use thereof. More particularly, disclosed are inhibitors of Aurora A (Aurora-2) protein kinase. Also disclosed are methods of treating diseases associated with protein kinases, especially diseases associated with Aurora-2, such as cancer.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72221705P | 2005-09-30 | 2005-09-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA96427C2 true UA96427C2 (en) | 2011-11-10 |
Family
ID=40107303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200805165A UA96427C2 (en) | 2005-09-30 | 2006-09-29 | Substituted pyrazole compounds |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN101316587B (en) |
UA (1) | UA96427C2 (en) |
ZA (1) | ZA200802786B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR074776A1 (en) * | 2008-12-18 | 2011-02-09 | Sanofi Aventis | METHOD TO TREAT MACULAR DEGENERATION; MODULATING THE PATIENT'S IMMUNE SYSTEM |
CN104024246B (en) * | 2012-03-27 | 2016-03-02 | 广东东阳光药业有限公司 | As the substituted pyrimidines derivative of Ou Ruola kinase inhibitor |
CN111349076B (en) * | 2018-12-20 | 2022-07-26 | 江苏恒瑞医药股份有限公司 | Crystal form of L-lysine salt of benzopiperidine derivative and preparation method thereof |
CN115925684A (en) * | 2021-12-03 | 2023-04-07 | 徐诺药业(南京)有限公司 | Pyrimidine derivative and preparation method and application thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60120193T2 (en) * | 2000-09-15 | 2007-03-29 | Vertex Pharmaceuticals Inc., Cambridge | PYRAZOL COMPOUNDS AS PROTEIN KINASE HEMMER |
ATE528303T1 (en) * | 2000-12-21 | 2011-10-15 | Vertex Pharma | PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS |
AU2003286711A1 (en) * | 2002-10-25 | 2004-05-13 | Vertex Pharmaceuticals Incorporated | Indazolinone compositions useful as kinase inhibitors |
-
2006
- 2006-09-29 UA UAA200805165A patent/UA96427C2/en unknown
- 2006-09-29 CN CN2006800446567A patent/CN101316587B/en not_active Expired - Fee Related
-
2008
- 2008-03-28 ZA ZA200802786A patent/ZA200802786B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200802786B (en) | 2009-03-25 |
CN101316587A (en) | 2008-12-03 |
CN101316587B (en) | 2013-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007041358A3 (en) | Substituted pyrazole compounds | |
TW200801008A (en) | Protein kinase inhibitors | |
WO2006055831A3 (en) | Kinase inhibitors | |
WO2007067781A3 (en) | 9-membered heterobicyclic compounds as inhibitors of protein kinases | |
MX2009005011A (en) | Imidazopyrazines as protein kinase inhibitors. | |
MXPA06010904A (en) | Tricyclic pyrazole kinase inhibitors. | |
MX2007003603A (en) | Methods for preparing indazole compounds. | |
MX2009013729A (en) | Imidazopyrazines as protein kinase inhibitors. | |
MX2009002377A (en) | Indazole derivatives as modulators of interleukin- 1 receptor-associated kinase. | |
UA95934C2 (en) | Pyridiazinone derivatives for tumour treatment | |
WO2009064486A3 (en) | Inhibitors of pim protein kinases, compositions, and methods for treating cancer | |
GEP20125368B (en) | Kinase inhibitors | |
WO2006050109A3 (en) | Novel kinase inhibitors | |
UA101478C2 (en) | Compounds useful as inhibitors of raf protein kinase | |
MX2009012719A (en) | Thiazoles and pyrazoles useful as kinase inhibitors. | |
IL173348A0 (en) | Thienopyridine and furopyridine kinase inhibitors | |
GEP20135785B (en) | Pyrrolopyrimidine compounds as cdk inhibitors | |
ATE432281T1 (en) | PYRROLOTRIAZINE KINASE INHIBITORS | |
MX2010006203A (en) | Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases. | |
HK1087700A1 (en) | Triazolopyridazines as protein kinases inhibitors | |
UA99621C2 (en) | Pyridazinone derivates | |
TW200621721A (en) | Methods of preparing indazole compounds | |
UA100540C2 (en) | 2-benzylpyridazinone derivatives as met kinase inhibitors | |
MX2008001538A (en) | 2-aminoaryl pyridines as protein kinases inhibitors. | |
CA2641347C (en) | Indazole-heteroaryl derivatives |